Fertility preservation in hematological cancer patients
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03419-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Dan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Fertility Preservation, Hematologic Neoplasms, Cryopreservation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: This work was supported by the Major Projects in Provincial and National Union Construction of Henan Medical Science and Technology Research Plan.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Among adolescents and young adults, hematological malignancies are the most common malignancies. Although the survival rate of hematological malignancies in young patients has been dramatically improved, due to the continuous improvement and development of tumor diagnosis and treatment options, cytotoxic therapies can significantly reduce a patient's reproductive capacity and cause irreversible infertility. The most two established solutions are embryo cryopreservation and oocyte cryopreservation which can be considered in single female. Sperm or testicular tissue cryopreservation in adult male are feasible approaches that must be considered before gonadotoxic therapy. A comprehensive consultation with reproductive specialists when once diagnosed is a significantly issue which would help those survivors who want to have children. In this article, we review germ cell toxicity, which happens during the treatment of hematological malignancies, and aims to propose safety, efficacy fertility preservation methods in younger patients with hematological malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Reproductive Medicine Center, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China. luckyzcl@qq.com.
Förderung
- This work was supported by the Major Projects in Provincial and National Union Construction of Henan Medical Science and Technology Research Plan
Zitieren
APA
Li, D., Zhao, Y. J., Wang, Q., Chu, M. W., Xie, J. K., & Zhang, C. L. (2024). Fertility preservation in hematological cancer patients. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03419-2
Vancouver
Li D, Zhao YJ, Wang Q, Chu MW, Xie JK, Zhang CL. Fertility preservation in hematological cancer patients. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03419-2
BibTeX
@article{Li2024,
author = {Li, Dan and Zhao, Yi-Jun and Wang, Qian and Chu, Man-Wei and Xie, Juan-Ke and Zhang, Cui-Lian},
title = {Fertility preservation in hematological cancer patients},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03419-2}
}
EUVIMED